Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AbboMax is a biotechnology company based in San Jose, California, specializing in the development and manufacture of high-quality antibodies and reagents for the life sciences research community. The company provides an extensive catalog of primary and secondary antibodies, synthetic peptides, and assay kits tailored for diverse research applications. Their product portfolio covers critical therapeutic areas including oncology, neuroscience, signal transduction, and infectious diseases. Beyond catalog products, AbboMax offers comprehensive custom services such as polyclonal and monoclonal antibody development, peptide synthesis, and protein purification. They serve a global customer base across academic institutions, pharmaceutical companies, and diagnostic laboratories, focusing on providing validated tools that ensure reproducible results.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AbboMax.